Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS034173-02
Application #
2273317
Study Section
Physiological Chemistry Study Section (PC)
Program Officer
Kitt, Cheryl A
Project Start
1995-06-01
Project End
1998-05-31
Budget Start
1996-06-01
Budget End
1997-05-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Henry M. Jackson Fdn for the Adv Mil/Med
Department
Type
DUNS #
City
Rockville
State
MD
Country
United States
Zip Code
20817
Driscoll, W J; Konig, S; Fales, H M et al. (2000) Peptidylglycine-alpha-hydroxylating monooxygenase generates two hydroxylated products from its mechanism-based suicide substrate, 4-phenyl-3-butenoic acid. Biochemistry 39:8007-16
Ritenour-Rodgers, K J; Driscoll, W J; Merkler, K A et al. (2000) Induction of peptidylglycine alpha-amidating monooxygenase in N(18)TG(2) cells: a model for studying oleamide biosynthesis. Biochem Biophys Res Commun 267:521-6
Mueller, S A; Driscoll, W J; Mueller, G P (1999) Captopril inhibits peptidylglycine- alpha-hydroxylating monooxygenase: implications for therapeutic effects. Pharmacology 58:270-80
Petrides, J S; Deuster, P A; Mueller, G P (1999) Lactic acid does not directly activate hypothalamic-pituitary corticotroph function. Proc Soc Exp Biol Med 220:100-5
Mueller, G P; Driscoll, W J; Eipper, B A (1999) In vivo inhibition of peptidylglycine-alpha-hydroxylating monooxygenase by 4-phenyl-3-butenoic acid. J Pharmacol Exp Ther 290:1331-6
Driscoll, W J; Mueller, S A; Eipper, B A et al. (1999) Differential regulation of peptide alpha-amidation by dexamethasone and disulfiram. Mol Pharmacol 55:1067-76